Trial Profile
Phase I trial of venlafaxine-deuterated (SD 254) in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Oct 2008
Price :
$35
*
At a glance
- Drugs Venlafaxine deuterated (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Auspex Pharmaceuticals
- 29 Oct 2008 New trial record.